American Financial Group, Inc. (NYSE: AFG) — A Superb Capital-Return Machine at Its Richest-Ever Multiple

Independent equity research note. Report date: 2026-06-26. All figures USD unless noted. Primary sources: SEC filings (10-K FY2025, 10-Q Q1-2026, DEF 14A 2026, Form 4 corpus) and public company disclosures.

⚡ Claude’s Take

This block is the author’s own independent opinion and general information, not investment advice. The analysis that follows (Sections 1–15) is presented position-free; only this block takes a view.

Verdict: HOLD / not-a-buy-here / accumulate only on a meaningful pullback. Fair-value zone ≈ $120–140 (≈2.1–2.4× book on an ~18% sustainable core ROE). A better entry is the low-$100s (≈1.8–2.0× book). Not-a-short. Medium conviction.

American Financial Group is a genuinely excellent business run by genuinely excellent, deeply-aligned operators. The Lindner family has built a federation of ~36 niche specialty-insurance businesses that compounds an 18–19% core operating ROE, has raised its regular dividend for 20 consecutive years, and — the signature move — periodically shovels excess capital back to owners through large special dividends (an $8/share special in 2022; ~$6.3B of total capital returned over five years, ~115% of earnings). The capital-allocation culture is best-in-class and the balance sheet is fortress-grade. If you want to own a disciplined, family-aligned, low-beta specialty insurer that treats shareholders like partners, this is one of the finest examples in the market. None of that is in dispute.

The problem is the price. AFG trades at 2.42× book — the 96.6th percentile of its own ten-year history, its richest-ever multiple — on core earnings that have gone sideways-to-down for five years ($993M in 2021 to $860M in 2025). And — importantly — this is not the MET/AIG “AOCI mirage”: AFG’s book is clean (the 2022 rate-shock AOCI hole self-cured to roughly zero), so 2.42× is real richness, the market capitalizing a high ROE on a deliberately lean equity base. The catch is that the high ROE rests partly on financial engineering (special dividends keep equity thin, mechanically lifting ROE) plus volatile alternative-investment income and a one-off 2025 crop windfall — not on best-in-class underwriting. AFG’s 91.0% combined ratio is a clear tier below RLI (83.6%), Arch’s P&C (~88%) and Chubb (low-90s); yet it commands an RLI/W.R. Berkley-class multiple. Meanwhile the specialty casualty book is visibly deteriorating on social inflation (its combined ratio drifted from 88.8% to 96.0% over three years), the broader specialty P&C cycle is softening, and the Lindner co-CEOs are 72 and 71 with no named successor. You are paying a top-of-history multiple for a tier-two-underwriting franchise at a cyclical plateau, with key-person succession unresolved.

So this is a wonderful company at a demanding price — the inverse of a margin-of-safety setup. The justified-P/B math says 2.42× already prices a permanently sustained ~18% ROE with no cycle reversion and capitalizes the family premium and special-dividend yield as forever. The reward for being right is roughly book-growth plus a ~2.5% base yield (plus episodic specials); the risk is a cycle/ROE disappointment into a peak multiple — an asymmetry that tilts the wrong way at $136. Framing (from the tape): beta 0.45, DividendYield +0.41, LowVolatility +0.41, Value +0.245; near its all-time high (−5% off), +16.7% over the past year — an income/low-volatility/quality name bid up for yield and safety, explicitly not cheap and not a falling knife. Conviction: medium. Bull-flip: core ROE holds ≥18% with Specialty Casualty combined ratio back below ~92% and alternative income normalized for 3–4 quarters — durable excellence that earns the multiple. Bear-flip: a Specialty Casualty reserve charge or combined ratio sustained above ~95–96%, or core ROE printing 14–15% — which would expose 2.42× book as a peak-multiple-on-peak-perception and trigger a de-rate toward 1.8–2.0×. Tag: “Great family, great dividends, demanding price.”

📈 Stock Price Action — Five-Year Event Map

On a total-return (dividend-adjusted) basis AFG has compounded steadily higher over five years — the adjusted price runs from roughly $78 (mid-2021) to an all-time high of $143.34 on 6 October 2025, and sits at $135.89 (25 June 2026), only ~5.2% off its high, near the top of a 52-week range of $116.62–$143.34. The defining feature of the chart is not volatility — beta is just 0.45 — but the steady grind up plus a stream of large cash distributions paid out along the way (an $8/share special in 2022, multiple $2–4 specials since). This is a low-drama compounder that returns cash, not a cyclical roller-coaster.

Cycle narrative. (1) The 2021 monetization of the annuity business reshaped AFG into a pure-play specialty P&C insurer and kicked off the special-dividend era — the stock re-rated as the market recognized a leaner, higher-ROE, capital-returning company. (2) 2022 delivered peak hard-market earnings and the record $8.00 special, but reported book value was simultaneously dented by the rate-shock AOCI hole (a book drag, not an earnings drag). (3) Through 2023 core earnings drifted off the peak as the specialty casualty book began absorbing social-inflation severity. (4) From 2024 into late-2025 the stock ground to new highs on steady book-and-dividend compounding, its 20th consecutive regular-dividend increase, and a defensive/income bid in a market that prized low-beta quality — reaching $143.34. (5) Since the high it has consolidated mildly as investors weigh a depressed alternative-investment year and Specialty Casualty drift against the 2025 crop windfall. The price moves are Fact; the attributed causes are Interpretation.

1. Executive Summary

American Financial Group is a Cincinnati-based, Lindner-family-controlled pure-play specialty property & casualty insurer operating as Great American Insurance Group — a federation of ~36 niche underwriting businesses spanning crop, transportation, ocean/inland marine, excess & surplus, executive/professional liability, workers’ compensation, fidelity, and surety. Since selling its annuity business to MassMutual in 2021, AFG has been a focused specialty underwriter with a defining corporate habit: underwrite for profit, hold only the capital needed to do so, and return the rest to shareholders — chiefly through a 20-year-growing regular dividend supplemented by large, episodic special dividends. In FY2025 the company wrote $10.7B of gross premium, earned a 91.0% combined ratio, and produced ~$860M of core operating earnings (~$10.29 core EPS) and a core operating ROE of roughly 18–19%.

The investment question is almost entirely about valuation, not quality. AFG is a high-quality, superbly-allocated business — but it trades at 2.42× book value, the 96.6th percentile of its own history and its richest-ever multiple (composite valuation 91st percentile; ~12.9× core earnings, 87th percentile). Crucially, this richness is real: unlike the life insurers whose 2022 AOCI losses created a false “richest-ever P/B,” AFG’s short-duration bond book pulled the AOCI hole back to roughly zero, so ex-AOCI book (~$58/share) ≈ GAAP book (~$58/share). The market is genuinely capitalizing AFG’s high ROE at a premium — and that ROE is itself flattered by a deliberately lean equity base (special dividends keep book thin, mechanically lifting ROE), by volatile alternative-investment income, and by a 2025 crop windfall. AFG’s underwriting — a 91.0% combined ratio — sits a clear tier below best-in-class specialty peers RLI (83.6%), Arch P&C (~88%), and Chubb (low-90s), even as AFG commands an RLI/W.R. Berkley-class book multiple.

The bull case: an 18–19% sustainable ROE, a 20-year dividend-growth record plus a special-dividend yield machine, deep family alignment, conservative reserving, and a fortress balance sheet justify a premium for a defensive, low-beta compounder. The bear case: the richest-ever multiple sits on flat-to-declining core earnings (down from $993M to $860M over five years), a softening cycle, a Specialty Casualty book deteriorating on social inflation (combined ratio 88.8% → 96.0%), heavy dependence on crop and alternative-investment swings, and an unresolved Lindner succession (co-CEOs aged 72 and 71). The justified-P/B framework shows 2.42× already requires a permanently-sustained ~18% ROE with no cycle reversion. This is a wonderful company priced for permanent excellence, with a thin margin of safety and an asymmetry skewed toward downside surprise. No recommendation or price target appears below this section (the labeled Claude’s Take above is the sole exception).

2. Business Overview

American Financial Group is an insurance holding company whose sole operating business, since the 2021 divestiture of its annuity arm, is specialty property & casualty insurance conducted through Great American Insurance Group. The model is a federation: roughly 36 distinct, largely autonomous niche underwriting units, each led by specialists with deep vertical expertise in a defined market (e.g., crop/multi-peril, trucking/bus physical damage and liability, ocean and inland marine, agricultural equipment, excess & surplus casualty, executive/professional liability, workers’ compensation, fidelity and crime, and contract/commercial surety). AFG makes money two ways: underwriting profit (it consistently runs a sub-100% combined ratio) and investment income on a ~$17B portfolio that includes a distinctive, Lindner-managed alternative-investment book (private equity and real estate).

Segment economics, FY2025 (from the FY2025 10-K, $M):

(Net earned premium $7,046M; the small residual between segment underwriting profit and the $629M total reflects “other specialty” and rounding.) Below the underwriting line, P&C net investment income was $725M, supplemented by alternative-investment income of $69M (down sharply from $158M in FY2024 and $163M in FY2023 — a key swing factor, discussed in Section 6).

Property & Transportation (~44% of GWP). Crop (multi-peril and crop-hail) and commercial transportation (trucking/bus). FY2025’s 87.8% combined ratio and 57% jump in underwriting profit were flattered by a record corn/soybean harvest — crop results are weather-dependent and do not recur reliably.

Specialty Casualty (~43% of GWP). Excess & surplus, executive/professional liability (D&O, E&O), general/umbrella/excess liability, and workers’ compensation. This is the segment under pressure: its combined ratio deteriorated from 88.8% (FY2023) to 96.0% (FY2025) and underwriting profit fell from $348M to $129M as social inflation (rising jury verdicts, litigation funding) drove loss severity in the longer-tail liability lines.

Specialty Financial (~13% of GWP). Fidelity, crime, surety, lender-placed/financial-institution products. The most consistently profitable segment (84.4% combined ratio), low-volatility and high-return.

Recurring vs. cyclical. Premium renews annually and is sticky in the niches AFG leads, but underwriting margin is cyclical and, within crop, weather-dependent. Investment income is the most recurring stream — except the alternative-investment slice, which is the single largest source of earnings volatility. The structural point developed later: AFG’s headline returns blend durable niche underwriting with a volatile alt-income tail and an episodic crop tail.

Verdict: A focused, diversified specialty underwriter with genuine niche depth and two distinct profit engines (underwriting + investments), but with more earnings volatility (crop, alternatives, social-inflation-exposed casualty) than the smooth compounding the multiple implies.

3. Industry Dynamics

AFG competes in specialty / excess & surplus (E&S) property & casualty insurance — structurally one of the better corners of insurance, but one now in the down-phase of its pricing cycle.

Structure. Specialty P&C is a large, fragmented, broker-intermediated market in which winners are defined by underwriting expertise in defined niches rather than scale or brand. It is structurally above-average because: the E&S channel can price and structure risks the admitted market won’t touch (pricing freedom, no rate-and-form regulation), specialist underwriting data and expertise create modest barriers, and the best operators earn through-cycle underwriting profits (sub-100% combined ratios) that most of the broad P&C industry cannot. The E&S segment has taken secular share from the admitted market for a decade — a genuine tailwind for specialists like AFG, W.R. Berkley, RLI, Kinsale and Arch.

Where in the Marathon capital cycle (2026)? The 2019–2023 hard market — driven by social inflation, reserve deficiencies, and reinsurance cost pass-through — has matured and is now softening unevenly:

• Property and short-tail rates are topping and rolling over as capital floods back; AFG’s renewal pricing is decelerating (management cited renewal rate increases of ~+5% ex-comp, the 39th consecutive quarterly increase but slowing).
• Workers’ compensation is in outright deflation (AFG pricing ~−3%), a long-running soft spot driven by benign frequency.
• Longer-tail casualty is firming in response to adverse liability trends — commercial auto rates up ~+14% (delivering AFG’s first underwriting profit in that line after ~15 years), excess liability strong — but firming casualty prices are the market’s response to rising losses, which is precisely the reserve risk that has dented AFG’s Specialty Casualty results.
• E&S is seeing “heightened competition” as MGAs and PE-fronted capital re-enter — the classic Marathon late-cycle signal that high returns attract capital that then compresses margins. Management has explicitly flagged the likelihood of future losses in casualty lines as competitors under-price.

The alternative-investment overlay. Unusually for a P&C insurer, AFG’s results are materially influenced by a ~$2.4B Lindner-managed private-equity and real-estate book whose returns swung from ~7% (2023) to ~2.5% (2025). This is a differentiator in good years and a drag in bad ones — and it injects an asset-cycle dependence atop the underwriting cycle.

Regulatory/structural factors. State-regulated (admitted lines) plus the more flexible E&S/surplus-lines framework; rated A+ (Superior) by A.M. Best, A by S&P. No single regulatory overhang comparable to health or life insurance.

Verdict: A structurally above-average industry (specialty/E&S) with a real secular tailwind — but late-cycle in 2026, with property/comp softening, casualty firming because losses are rising, and capital re-entering. Earnings across the sector are at a cyclical plateau, not a trough; AFG’s premium multiple is being awarded at the wrong point in the cycle.

4. Competitive Position

The honest answer: AFG has a narrow, niche-by-niche underwriting advantage plus a strong management/family premium — but it is a tier below the best-in-class specialty underwriters, and the premium multiple rests more on capital-return culture and a lean-equity ROE than on a wide structural moat.

Applying the Greenwald taxonomy:

• Customer captivity / switching costs: Modest. In niche lines where AFG is a top-3–5 writer (certain crop, surety, transportation, fidelity programs), incumbency, claims expertise, and specialized forms create some stickiness — but brokers re-tender annually and capital is mobile.
• Network effects: None.
• Proprietary cost / data advantage: Real but narrow. Decades of granular loss data and underwriting expertise in defined niches (crop/MPCI, surety, workers’ comp) constitute a genuine information edge in those pockets — the source of AFG’s through-cycle underwriting profit. But it is a collection of narrow edges, not a single wide moat.
• Economies of scale + captivity: Limited. AFG is mid-sized (~$10.7B premium); it is not the scale leader in most of its lines, and the federated model deliberately keeps units small and specialized.

The financial tell. The clinching evidence on moat width is the combined ratio. AFG’s 91.0% is good — better than the ~95% all-lines industry average and a respectable through-cycle result — but it sits a clear tier below the genuine best-in-class: RLI at 83.6%, Arch’s P&C at ~88%, Chubb in the low-90s with vastly greater scale, and W.R. Berkley (the closest structural analog) typically a point or two better with a similar federated model. AFG’s elite-looking 18–19% ROE therefore does not come primarily from superior underwriting; it comes from (i) a deliberately lean equity base (special dividends keep book thin, so the same dollar of profit divides into a smaller denominator), (ii) alternative-investment income in good years, and (iii) reserve-light niche characteristics. Strip the financial engineering and the alt tail, and AFG’s underwriting franchise is good-not-great.

What is genuinely strong is the management/family premium: the Lindners are exceptional, disciplined, owner-operators whose interests are deeply aligned (a ~14–15% family stake), whose comp is 100%-formula on core ROE and book-value growth, and whose capital-allocation record (Section 7) is best-in-class. That premium is real and worth paying something for — but it is a management edge (reproducible in principle, and exposed to succession risk) more than a structural one.

Direct comparison. Against W.R. Berkley (the closest peer — federated specialty, owner-aligned, similar combined ratio), AFG is comparable in quality but Berkley’s underwriting is marginally better and its growth higher. Against RLI, AFG is clearly a tier behind on underwriting (91% vs 84%). Against Arch (ACGL), AFG lacks the diversified reinsurance/mortgage engines and the capital-fungibility advantage, and earns its ROE more from leverage-of-equity than from underwriting. Against Cincinnati Financial / Old Republic / Mercury, AFG is a clear notch above on both ROE and underwriting discipline.

Verdict: A durable advantage exists — a genuine collection of narrow niche-underwriting edges plus an exceptional, aligned ownership culture — but it is narrow and management-dependent, not a wide structural moat. Worth owning at the right price; not deserving of a best-in-class multiple, which is precisely what the market is currently awarding it. If the family premium fades (succession) or the cycle turns, the moat thins.

5. Growth History and Forward Opportunities

History. AFG’s growth is best understood as per-share value compounding, not premium expansion. Gross written premium has grown at a modest low-single-to-mid-single-digit pace (FY2025 GWP $10.7B, +2%); the company deliberately does not chase top-line growth, shrinking lines where pricing is inadequate (workers’ comp, soft E&S) and leaning into firming ones (commercial auto, excess liability). The real “growth” engine has been book value per share plus accumulated dividends, compounded through underwriting profit, investment income, and disciplined capital return. Core operating earnings, however, have been flat-to-declining: $993M (2021) → $993M (2022) → $895M (2023) → $902M (2024) → $860M (2025) — a five-year plateau, with the mix shifting (crop and financial up, casualty and alt-income down).

Composition. Predominantly organic. M&A is limited to disciplined niche bolt-ons (e.g., Verikai, a data/AI underwriting analytics business; historical crop/specialty tuck-ins) and pruning of sub-scale or underperforming units (the Crop Risk Services divestiture; the April-2026 sale of the Charleston marina real-estate asset for a ~$125M gain). AFG does not do transformational acquisitions and does not over-pay.

Forward opportunities.

• E&S share gains: the secular migration of risk into the E&S channel continues to favor specialists; AFG can grow profitable E&S casualty and property where pricing holds.
• Casualty re-pricing: as commercial auto and excess liability firm, AFG can expand in lines it had shrunk — its commercial-auto turn to profitability after ~15 years is a template.
• New niches via bolt-ons and analytics: Verikai-style data capabilities and new specialty programs.
• Capital deployment: in a soft market, AFG’s “growth” lever is returning capital (special dividends) and opportunistic buybacks, converting excess capital into per-share value rather than chasing unprofitable premium.

The honest counter-point. With core earnings flat for five years, the growth story is really a compounding-plus-distribution story. Total shareholder return has come from dividends (regular + special) and a rising multiple, not from earnings growth. If the multiple stops rising (it is already at the 96.6th percentile) and core earnings stay flat, forward returns compress to roughly the dividend yield plus low-single-digit book growth.

Verdict: High-quality but low-growth — disciplined per-share compounding and distribution, not expansion. The quality is in the return of capital and the avoidance of value destruction, not in a growth runway. That is a fine thing to own, but it caps the upside that a 2.42× book multiple implicitly demands.

6. Financial Quality

AFG’s financials are high-quality and conservatively stated — but the level of returns is flattered by mix and engineering, and the earnings trend is flat, which matters enormously at a peak multiple.

Five-year trend (reconciled to 10-K/10-Q; $M except per-share):

*FY2021 GAAP net earnings are distorted by the ~$1B+ gain on the MassMutual annuity sale and discontinued operations — use core ($993M).

(1) The P/B-on-real-vs-depressed-book question — RESOLVED: the richness is REAL. This was the crux. The 2022 rate shock opened an AOCI hole (−$543M), which could have created a MET/AIG-style “richest-ever P/B mirage” on rate-crushed book. It did not: AFG’s short (~3-year) bond duration pulled the unrealized losses back toward par, and AOCI recovered to just −$50M by end-2025. Ex-AOCI book value per share (~$58.46) is essentially identical to GAAP book (~$57.86). So P/B 2.42× is genuine richness on a clean book, not an accounting artifact. What does keep book lean is deliberate special dividends: GAAP equity fell from ~$6.8B (2020) to $4.8B (2025) despite ~$5.5B of cumulative earnings, as AFG paid out 72–220% of earnings in various years. That lean base elevates both P/B and ROE simultaneously — 2.42× book is the market capitalizing a real ~18–19% core ROE, accepting that the ROE is partly a denominator effect.

(2) Core vs. GAAP — clean. Outside the FY2021 annuity-sale distortion, core and GAAP earnings track closely (FY2025 core $860M vs GAAP $842M). AFG’s “core net operating earnings” sensibly excludes realized investment gains/losses and special items; the gap is small and the disclosure is honest. Core operating ROE has run ~18–19.5% over FY2023–25, verifying management’s high-teens/~20% target. (Note: some aggregators show a 25–27% ROE by dividing into the very thin equity base; the cleaner read is ~18–19%.)

(3) Earnings — peak or trough? Genuinely mixed/mid-cycle. Core earnings are flat-to-declining ($993M → $860M). The components pull in opposite directions:

• Peak/transitory tailwinds: the FY2025 crop windfall (Property & Transportation combined ratio 87.8% on a record harvest) and the maturing hard market.
• Trough/depressed factors: alternative-investment income collapsed to $69M (2.5% return) from $158–163M (6–7%) — roughly $0.85+/share of normalized headroom currently missing, and recovering in Q1-2026 (core +36% y/y); and Specialty Casualty deteriorated to a 96.0% combined ratio on social inflation.
• Not release-flattered: favorable prior-year reserve development has already normalized down ($226M FY2023 → $70M FY2024 → $86M FY2025), so FY2025 is not propped up by reserve releases — a point of quality.

A reasonable normalized core EPS is ~$10.75–11.25 with a normalized core ROE of ~18–19%, assuming alt income reverts toward ~6%, crop normalizes off the windfall, and Specialty Casualty stabilizes — roughly the current level, i.e. earnings are at a plateau, not poised to inflect sharply either way.

(4) Investment portfolio. Total cash and investments ~$17.2B. Fixed-income NII of $725M has benefited from the higher-rate cycle (a tailwind now cresting). The ~$2.4B alternative-investment book (equity-method PE/real estate) is the largest source of earnings volatility and the principal QoE flag — its income is in core, so a weak alt year (like 2025) depresses “core” earnings and a strong year inflates them.

(5) Balance sheet. Solid: debt of ~$1.85B, debt/total-capital ~27.5% (up from ~24% as buybacks/specials shrank equity — worth watching but comfortable), A+ (Superior)/A rated, ample holding-company liquidity, and catastrophe exposure tightly controlled (modeled 1-in-500-year net exposure <3% of equity). Excess capital above what’s needed to write business is the fuel for the special dividends.

(6) QoE flags. Alt-income volatility; crop-year weather dependence; and a ~$125M pretax gain on the April-2026 Charleston marina sale that books into FY2026 core earnings (AFG records real-estate gains in core) — a one-time item that will flatter FY2026 and should be normalized out. Otherwise clean: no divergence of net income from operating cash flow, conservative reserves, honest core/GAAP reconciliation.

Verdict: Genuinely high-quality and conservatively stated — but the return level is flattered by lean-equity engineering, alt income, and crop, and the earnings trend is flat. Do economics improve with scale? Only modestly; the swing factors are mix and cycle, not scale. The risk here is the multiple, not a hidden earnings cliff — but flat earnings at a peak multiple is its own kind of risk.

7. Capital Allocation

This is AFG’s standout strength and the single best reason to own it — capital allocation is best-in-class and the interests of management and outside shareholders are about as aligned as they get in public markets.

The capital-return machine. Over FY2021–2025 AFG returned roughly $6.3B to shareholders (~$5,665M of dividends + ~$642M of buybacks) against ~$5,474M of GAAP net earnings — i.e. it paid out ~115% of earnings, deliberately drawing down the ~$3.5B of MassMutual annuity-sale proceeds and any capital not needed to write business at target returns. The mechanism has two parts:

• A growing regular dividend — increased for 20 consecutive years, raised ~+10% in October 2025 to a run-rate of ~$3.40/share (~2.5% yield before specials). This is the steady, signal-rich component.
• Large special dividends, declared roughly twice a year, sized explicitly to excess capital above what the business needs — textbook Marathon-style counter-cyclical discipline (return capital when underwriting opportunity is scarce rather than chase unprofitable premium). The cadence: $8.00 (May-2022) tapering to $4.00 (Nov-2024), $2.00 (Mar/Nov-2025), $1.50 (Feb-2026) as the special-dividend “war chest” from the annuity sale was distributed. In 2025, total returns were ~$707M = $274M regular + $334M special + $99M buyback.

Buybacks are opportunistic and secondary ($0 in FY2024, $99M in FY2025); the share count falls only ~1%/year, so dividends, not repurchases, are the engine. This is a defensible choice — buying back stock at 2.4× book is far less attractive than at ACGL’s 1.4×, so AFG sensibly favors dividends at these valuations.

M&A. Disciplined and small: niche bolt-ons (Verikai analytics; historical crop/specialty tuck-ins) and pruning of underperformers (Crop Risk Services divestiture; Charleston marina sale). No transformational deals, no overpayment, no goodwill blow-ups — exactly what you want from an insurer.

Compensation — exemplary alignment. The co-CEO incentive structure is 100% objective formula (no discretionary CEO bonus pool), tied to core operating ROE (ex-AOCI), growth in book value per share, and a third formula bucket; long-term incentives use a three-year ROE metric plus four-year-cliff restricted stock. The metrics reward profitable underwriting and per-share value creation, not premium growth — precisely correct for a cyclical insurer. Co-CEO total compensation (~$11.0–11.2M each in 2025) is reasonable for the size and performance.

Insider/ownership. The Lindner family controls ~14–15% (Carl H. Lindner III ~6.8%, S. Craig Lindner ~6.2%, Craig Lindner Jr. ~2.2%, plus trusts and foundations) — deep, durable alignment. Across the 193-filing Form 4 corpus, activity is routine grants (code A), tax-withholding (F), and gifts (G), with only occasional small officer sales and zero open-market purchases — neutral, as expected for a family already owning ~15%. Governance watch-items are the controlled-company status and related-party features (the Lindner-managed alternative-investment/real-estate book, charitable-foundation cross-holdings), mitigated by majority voting, a lead independent director, and formula-only CEO pay.

Verdict: Intelligent, disciplined, owner-aligned capital allocation of the highest order — a 20-year dividend-growth record, excess-capital special dividends, no value-destructive M&A, and a comp scheme bolted to ROE and book value. This is the part of the thesis that is not in doubt, and it justifies a premium. The only debits: paying out >100% of earnings compounds book value slowly, and recent returns have leaned partly on non-recurring sources (annuity proceeds, marina gain, alt gains).

8. Changes and Headwinds — Last Two Years

Specialty Casualty deterioration (the key operating headwind). The combined ratio of the Specialty Casualty segment drifted from 88.8% (FY2023) to 96.0% (FY2025), and segment underwriting profit fell from $348M to $129M, as social inflation drove severity in longer-tail liability lines. Management has been raising casualty rates and tightening terms in response, but firming casualty prices are a reaction to rising losses — and this is the franchise’s most reserve-sensitive exposure. This is the headwind most capable of disappointing a peak multiple.

Alternative-investment income collapse. Alt income fell from ~$158–163M (6–7% returns) in 2023–24 to $69M (2.5%) in FY2025, with a slightly negative print early in the year — a major swing factor that depressed FY2025 core earnings by roughly $0.85+/share versus a normalized ~6% return. It is recovering (Q1-2026 core earnings +36% y/y), which cuts both ways: it confirms the trough but also means a chunk of the recent “improvement” is a volatile asset-cycle rebound, not durable underwriting.

The softening cycle. Property and workers’-comp pricing is falling (comp ~−3%), E&S competition is intensifying as MGAs/PE capital re-enter, and renewal-rate momentum is decelerating (~+5% ex-comp, slowing). Management has flagged the likelihood of future casualty losses as competitors under-price — a candid, late-cycle warning.

Lindner succession (the central unresolved risk). Co-CEOs Carl H. Lindner III and S. Craig Lindner are 72 and 71 with no named successor. The next generation is represented on the board (Craig Lindner Jr.; son-in-law Mark Thompson), but the transition of the underwriting-and-capital-allocation culture that is the franchise’s premium is unaddressed publicly. For a company whose moat is ~75% management, this is material.

Positive developments. The 20th consecutive regular-dividend increase (+10%, Oct-2025); A+ ratings affirmed; the Charleston marina sale (~$125M gain); commercial auto turning to underwriting profit after ~15 years; conservative reserves (normalized but still favorable development). The crop windfall boosted FY2025.

Verdict: Net neutral-to-mildly-negative. Capital-return discipline and ratings are intact and the regular-dividend streak continues, but the operating environment has turned (Specialty Casualty drift, soft cycle, alt-income volatility) and the succession question is unresolved — and none of these are reflected in a richest-ever multiple. The changes weaken the case for paying up, even if they do not break the franchise.

9. Risk Analysis (Risk Matrix)

Net risk read: No solvency or balance-sheet risk. The dominant risks are valuation (a rich multiple on flat earnings), Specialty Casualty reserves, alt-income/crop volatility, and succession — a cluster that all argues the same thing: the price leaves little room for the cyclical and key-person disappointments that are reasonably likely over a multi-year hold.

10. Valuation Discussion (Embedded Expectations)

The right lens. For AFG the appropriate metrics are price-to-book against through-cycle ROE (justified P/B), a normalized core P/E, and the total distribution yield (regular + special). On all three, AFG is expensive on its own history: P/B 2.42× (96.6th percentile), core P/E ~12.9× (87.5th percentile), composite valuation 91st percentile — and ROIC.ai’s own-history multiple series corroborates AZI: 2025 sits at the top of AFG’s 2014–2025 band on both data sources. This is a richest-ever valuation, and (per Section 6) it is real, not an AOCI artifact.

Peer comparison (approximate, current):

The central tension. AFG’s P/B is exceeded only by RLI and Berkley — yet those two run 84–90% combined ratios versus AFG’s 91.0%, i.e. better underwriting. AFG’s 18–19% ROE tops Chubb, Travelers and Arch, whose underwriting is a tier better — because AFG’s ROE edge comes from lean-equity engineering + alt income + reserve-light niches, not from best-in-class underwriting. So at 2.42× book, the market is paying an RLI/Berkley-class multiple for tier-two underwriting, justified only if you treat the family/management premium and the special-dividend yield as permanent and the ROE as immune to cycle reversion.

Embedded expectations. Back-solving justified P/B = (ROE − g) / (COE − g): at a cost of equity of ~9–10%, long-run growth ~3–5%, and an 18% ROE, the formula yields a ~2.1–3.25× band — so 2.42× is internally consistent only if an ~18% core ROE is sustained essentially permanently, with no cycle reversion, and it capitalizes the family premium and distribution yield as forever. There is no margin of safety for mean-reversion — if ROE drifts to 14–15% (very plausible given casualty deterioration + a normalizing crop year + soft cycle), the justified multiple falls toward ~1.7–1.9×.

Scenario analysis (value zones, not targets; book ~$58, normalized core EPS ~$11):

• Bear (~$100–116): Specialty Casualty stays ~96%+, crop normalizes off the windfall, alt income only partially recovers → core EPS ~$9.5, ROE 14–15%; both earnings and multiple revert, de-rate to ~1.8–2.0× book. (Earnings and multiple compress together — the danger of a peak multiple on cyclical earnings.)
• Base (~$128–148): core EPS ~$11, ROE ~18%, multiple holds ~2.2–2.5× book; total return ≈ book growth + ~2.5% base yield + episodic specials — a fair-to-fully-valued grind. Most likely.
• Bull (~$155–175): alt income normalizes to ~6%, crop and casualty cooperate, core EPS $11.5–12, ROE 19–20%, multiple expands to ~2.6–2.8×, large specials resume — requires both durable elite returns and further multiple expansion from an already-record level.

Embedded-expectations conclusion: At 2.42× a clean book, the market is pricing AFG for permanent excellence — a sustained ~18% ROE, the family premium, and the special-dividend yield, all as forever, at a cyclical plateau and with succession unresolved. That is a demanding bar. The asymmetry skews toward downside surprise: limited multiple-expansion headroom (already 96.6th percentile) against real cyclical and key-person risks. No price target, no recommendation.

11. Variant Perception

Consensus. The market views AFG as a deservedly-premium, owner-aligned specialty compounder — a high-ROE, low-beta, dividend-growing “sleep-well-at-night” insurer whose special-dividend yield and family stewardship warrant a rich multiple. The stock near its all-time high, the 20-year dividend streak, and the defensive bid all reflect a consensus that AFG is a quality name worth paying up for. Consensus is essentially “high-quality, fairly-to-fully valued, hold.”

The strongest bull case. AFG is a best-in-class capital allocator with a 20-year dividend-growth record and a special-dividend machine that has returned ~$6.3B (≈115% of earnings) in five years; an 18–19% sustainable core ROE; deep family alignment (~15% stake, formula-only comp); conservative reserves; a fortress, A±rated balance sheet; and a defensive, 0.45-beta profile that holds up in drawdowns. The alt-income trough and Specialty Casualty drift are cyclical and already recovering (Q1-2026 core +36%); buy a superb, aligned compounder and clip a growing dividend plus episodic specials while the family keeps doing what it has done for decades. Quality of this kind deserves a premium and rarely gets cheap.

The strongest bear case. The richest-ever multiple (2.42× book, 96.6th percentile; ~12.9× core, 87th) sits on flat-to-declining core earnings ($993M → $860M over five years), in a softening cycle, with the Specialty Casualty book deteriorating on social inflation (88.8% → 96.0%), heavy dependence on volatile alt income and weather-driven crop, and an unresolved Lindner succession (co-CEOs 72 & 71). The high ROE is partly financial engineering (lean equity from special dividends) rather than best-in-class underwriting — AFG’s 91% combined ratio is a tier below the RLI/Berkley peers whose multiple it commands. You are paying a peak multiple for a tier-two-underwriting franchise at a cyclical plateau; the justified-P/B math leaves no margin of safety, and the realistic outcomes are a fair-value grind (return = yield + low-single-digit book growth) or a de-rate if the cycle or a casualty reserve charge bites.

The 3–5 assumptions that matter most:

1. Sustainability of the ~18% core ROE — permanent, or does it revert to 14–15% as casualty/crop/alt normalize and the cycle softens?
2. Specialty Casualty reserve adequacy — does the 88.8%→96.0% drift stabilize, or is there a charge coming in the longest-tail lines?
3. Alternative-investment normalization — does alt income revert to ~6%, and how much earnings volatility does it keep injecting?
4. Lindner succession — orderly transfer of the management/family premium, or a discount as the question lingers?
5. Multiple durability — will the market sustain a 96.6th-percentile multiple, or does mean-reversion in valuation do the damage even if the business is fine?

Falsification tests. Falsifies the bull: a Specialty Casualty reserve charge or a combined ratio sustained above ~95–96%, or core ROE printing 14–15% for a few quarters → exposes the peak-multiple-on-peak-perception and triggers a de-rate toward 1.8–2.0× book. Falsifies the bear: core ROE holding ≥18% with Specialty Casualty combined ratio back below ~92% and alt income normalized for 3–4 quarters, plus resumed large specials → durable elite returns that earn the premium. The two observables that settle it: the Specialty Casualty combined ratio and realized core ROE.

Factor/positioning read. The tape says “income/low-vol/value name bid up for yield and safety, near its highs”: beta 0.45, DividendYield +0.41, LowVolatility +0.41, Value +0.245, Market +0.40; rs_12m +13.5, only −4.4% off the peak, +16.7% over the past year, max drawdown a shallow −13%. Factor-similar peers are the dividend-paying insurers ORI, SAFT, CINF, AFL, TRV, HIG, EIG, MCY. This is the opposite of a falling knife or a contrarian value name — it is a richly-priced quality/income compounder near its highs, where the asymmetric surprise is a negative one (cycle/ROE/succession disappointment into a peak multiple), the mirror image of a name like Arch trading at 1.40× book.

12. Fact vs. Interpretation Table

13. Open Questions

1. Is the ~18% core ROE durable or partly a denominator effect? How much of the premium ROE survives if the special-dividend pace slows and equity rebuilds, and if alt income and crop normalize?
2. How adequate are Specialty Casualty reserves? Is the 88.8%→96.0% drift the worst of it, or is a reserve charge building in the longest-tail liability lines?
3. What is the normalized alternative-investment return, and how much earnings volatility will the ~$2.4B Lindner-managed book keep injecting?
4. Lindner succession: who runs the company and allocates capital after the current co-CEOs, and does the culture/premium transfer intact?
5. How deep will the specialty soft cycle go, and how much casualty under-pricing by MGA/PE entrants ultimately shows up as losses (management has flagged this)?
6. Will the market sustain a 96.6th-percentile multiple on flat earnings, or does valuation mean-reversion do the damage independent of operating results?
7. How should the recurring real-estate gains (e.g., Charleston marina) booked in “core” be treated — are these a legitimate, repeatable part of the model or one-time items inflating core?

14. What Must Be True

For the bull case (the premium multiple is earned; AFG keeps compounding at a high ROE):

• Core operating ROE must hold ≥18% through the soft cycle — not revert to 14–15%.
• Specialty Casualty combined ratio must stabilize/recover below ~92% (no social-inflation reserve charge).
• Alternative-investment income must normalize toward ~6% and crop must not collapse.
• The Lindner succession must be resolved without eroding the management/family premium.
• The market must sustain (or expand) a 96.6th-percentile multiple.
• Falsification test: if Specialty Casualty CR stays above ~95–96% or core ROE prints 14–15% for several quarters, the premium is not earned → de-rate toward 1.8–2.0× book.

For the bear case (richest-ever multiple on flat earnings de-rates):

• Core earnings must stay flat-to-down as the cycle softens and casualty/crop/alt normalize.
• Specialty Casualty drift must continue or produce a reserve charge.
• The multiple must mean-revert from its 96.6th-percentile extreme.
• Falsification test: if core ROE holds ≥18% with Specialty Casualty CR back below ~92% and normalized alt income for 3–4 quarters and resumed large specials, the bear thesis is dead — AFG is sustaining elite, well-capitalized returns and the premium is justified.

Both falsifiers key off the same two observables: the Specialty Casualty combined ratio and the realized core operating ROE. Watch those each quarter; they settle the debate.

The analysis above (Sections 1–14) is presented without an investment recommendation or price target. The sole, clearly-labeled exception is the opinion block at the top, which is the author’s own independent view.

15. Source Appendix

See Appendix B — Source Appendix below for the full evidence trail with URLs and access dates, and Appendix A — Diligence Questionnaire for the standard diligence question set.

APPENDIX A — Standard Diligence Questionnaire

American Financial Group, Inc. (NYSE: AFG) — supplemental to the research memo (not counted toward the memo length standard). Report date 2026-06-26. Answers grounded in the research log; Fact / Interpretation / Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? (1) Is the richest-ever P/B (2.42×) justified by a sustainable ~18% ROE, or is that ROE partly lean-equity engineering? (2) How adequate are Specialty Casualty reserves given the social-inflation drift (88.8%→96.0%)? (3) What is normalized alternative-investment income? (4) Who succeeds the Lindner co-CEOs (72 & 71)? (5) How much of FY2025 earnings is the one-off crop windfall? (6) Will the special dividends continue now that the annuity proceeds are largely distributed?

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Fact/Interpretation: Mixed / a plateau. Peak factors: FY2025 crop windfall (P&T CR 87.8%), maturing hard market. Trough factors: alt income depressed ($69M/2.5% vs $158-163M/6-7%), Specialty Casualty deteriorated to 96.0%. Net: core earnings flat ($993M→$860M over 5yr), neither clearly peak nor trough.

Driven by external environment or internal actions? Both. The earnings level is heavily external (crop weather, alt-market returns, the P&C pricing cycle, social inflation). The capital-return discipline and niche selection are internal and durable.

How stable are revenues? Premium is sticky and renews annually but margin is cyclical; crop is weather-dependent; alt income is volatile. Revenue grows slowly by design (GWP +2% FY25) — AFG won’t chase unprofitable premium.

Outlook / market size? Large, mature specialty/E&S P&C with a secular E&S share-gain tailwind, but softening pricing in 2026. Growth is per-share compounding + distribution, not top-line expansion.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? More — property/workers’-comp softening, E&S competition from MGA/PE capital re-entering (Marathon late-cycle); casualty firming because losses are rising.

How profitable (ROIC/ROE)? Core operating ROE ~18-19% (elite-looking, but flattered by lean equity + alt + reserve-light niches). Combined ratio 91.0%.

How profitable is the industry — barriers? Specialty/E&S is above-average (pricing freedom, underwriting-expertise barriers), but fragmented and cyclical; AFG is a top-3-5 writer in several niches, not the scale leader.

Can the business be understood? Moderately — the federated ~36-niche model, combined-ratio math, and the special-dividend mechanism are learnable, but reserve adequacy and the alt-investment book require judgment.

Undermined by foreign low-cost labor? No.

Do brands matter? Switching costs? Modest — incumbency, claims expertise and specialized forms create niche stickiness; brokers re-tender annually.

Financial Condition & Balance Sheet

Assets not fully recognized? The ~$2.4B alternative-investment (PE/real-estate) book carries embedded gains realized episodically (e.g., Charleston marina ~$125M, 2026). Conservatively-reserved redundancy is off-balance-sheet value. Interpretation.

Off-balance-sheet liabilities? None material disclosed; reserve adequacy (especially long-tail casualty) is the key on-balance-sheet estimation risk.

How conservative is the accounting? Conservative — favorable (though normalizing) reserve development, honest core/GAAP reconciliation, short bond duration (so AOCI self-cured), tightly controlled cat exposure. Watch: alt income is carried in “core,” adding volatility.

How CapEx-hungry? Capital-light operationally; “capital” is underwriting capacity. Excess capital is returned rather than reinvested in physical assets.

Capital Allocation & Management

How much FCF, and how is it used? Substantial; returned aggressively — ~$6.3B over FY21-25 (~115% of earnings) via a 20-year-growing regular dividend (~$3.40/sh, ~2.5% yield) plus large special dividends (~2×/yr, sized to excess capital) plus opportunistic buybacks.

Significant acquisitions? Disciplined niche bolt-ons (Verikai analytics; historical crop/specialty) and pruning (Crop Risk Services divestiture; Charleston marina sale). No transformational M&A.

Buying back shares? Opportunistically and secondarily ($0 FY24, $99M FY25); share count falls only ~1%/yr. Dividends, not buybacks, are the engine — sensible given the 2.4× book valuation.

Issuing shares to insiders? Routine equity comp only; no excessive issuance.

Compensation policy? Fact: 100%-formula co-CEO incentives on core operating ROE (ex-AOCI) + book-value-per-share growth; LTI on 3-year ROE. Rewards profitable underwriting and per-share value, not premium growth. Co-CEO pay ~$11M each (2025), reasonable.

Motivations of management? Owner-operators — Lindner family ~14-15% stake; per-share value creation and capital return, deeply aligned. Watch: controlled-company status, related-party alt/RE management, succession.

Valuation & Market Data

ADR, MLP, or K-1 issuer? None — ordinary NYSE common stock (Delaware/Ohio domestic filer); not an ADR, MLP or K-1.

Dividend policy? Growing regular dividend (20 consecutive annual increases, ~2.5% yield) PLUS large episodic special dividends — the defining feature.

How profitable? Highly (18-19% core ROE) — see above, with the lean-equity caveat.

Net income diverging from cash from operations? No material divergence; clean cash conversion.

Risks & Downside

What would cause the stock to decline? A valuation de-rate from the 96.6th-percentile multiple; a Specialty Casualty reserve charge; a poor crop year; weak alt-investment returns; core ROE reverting to 14-15%; a disorderly Lindner succession; a deeper soft cycle.

Risk of catastrophic loss? Low — A+ rated, conservative reserves, cat exposure <3% of equity (1-in-500), modest leverage (debt/cap 27.5%).

Chance of total loss? Very low — fortress balance sheet, diversified niches, disciplined underwriting.

Recent News & Events

Has the business environment changed recently? Yes — specialty P&C pricing softening; Specialty Casualty deteriorating on social inflation; alt income troughed in 2025 (recovering Q1-2026); crop windfall boosted FY2025.

Significant acquisitions? None major; Charleston marina sale (~$125M gain, April-2026); ongoing niche bolt-ons/pruning.

Change in accounting policies? None material; AOCI hole from 2022 rate shock self-cured by 2025.

Recent changes — markets, facilities, management? 20th consecutive regular-dividend increase (+10%, Oct-2025); A+ ratings affirmed; commercial auto turned to underwriting profit after ~15 years; Lindner succession unresolved (co-CEOs 72 & 71; next-gen Craig Lindner Jr. and Mark Thompson on board).

APPENDIX B — Source Appendix

American Financial Group, Inc. (NYSE: AFG) — Report date 2026-06-26. Public primary sources prioritized; all material facts traceable to filings.

Primary — SEC Filings (CIK 0001042046)

Primary — Quantitative Data Helpers

Peer Cross-Read (public company filings)

Key Figures Quick-Reference (all reconciled to filings)

• FY2025: GWP $10,694M (+2%); NWP $7,110M; NEP $7,046M; underwriting gain $629M; combined ratio 91.0%; P&C NII $725M; alt-investment income $69M (2.5% return).
• Sub-segment FY2025 CRs: Property & Transportation 87.8% (crop windfall) / Specialty Casualty 96.0% (from 88.8% FY23) / Specialty Financial 84.4%.
• Core operating earnings: $993M (FY21) → $993M (FY22) → $895M (FY23) → $902M (FY24) → $860M (FY25); core EPS ~$11.6 → ~$10.29. Core operating ROE ~18-19%.
• Book value per share ~$56-58 (GAAP) ≈ ex-AOCI (AOCI −$543M in 2022 → −$50M in 2025; richest-ever P/B is REAL, not a mirage).
• P/B ~2.42× (96.6th pctile own history); core P/E ~12.9× (87.5th); composite 91st.
• Capital returned FY21-25 ~$6.3B (~115% of earnings); 2025: $707M ($274M regular + $334M special + $99M buyback). 20th consecutive regular-dividend increase (+10% Oct-2025, ~$3.40/sh, ~2.5% yield).
• Debt/total-capital ~27.5%; total cash & investments ~$17.2B; A+ (Superior)/A rated. Cat exposure 1-in-500 net <3% of equity.
• Lindner family ~14-15% ownership (Carl III ~6.8%, Craig ~6.2%, Craig Jr. ~2.2% + trusts/foundations); co-CEOs aged 72 & 71, no named successor.
• Charleston marina sale ~$125M pretax gain (April-2026, books into FY2026 core).
• Price $135.89 (2026-06-25); market cap ~$11.5B; ~5.2% off ATH $143.34 (2025-10-06).